Memphis Pharmaceuticals
Last Updated:
- 219.01 EGP
- 2.96
- 1.37%
ممفيس للادوية والصناعات الكيماوية
ممفيس للادوية
Symbol :
MPCI
ISIN :
EGS38351C010
52-Week Range :
47.15
-
232.95
Turnover Ratio :
2.79
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Basic Information
-
Activity :Memphis Pharmaceutical and Chemical Industries (known as: Memphis Pharmaceutical) is a public company, listed on Egyptian Exchange (EGX) since September 1995. Memphis Pharmaceutical operates within the...
-
Industry Group :pharmaceuticals Research and Biotechnology
-
Sub-Industry :
-
ISIN :EGS38351C010
-
Contact Person :
-
Established On:20-Jul-1940
-
Stock Listing On :27-Sep-1995
-
No of Employees :1,169 Employees as of 2025
-
Outstanding Shares :22,750,000
-
Free Float Shares :
-
Par Value :
-
Paid Capital :
-
Market Cap :
-
Authorized Capital :
Indices Membership
| Action | Date | Index | Provider |
|---|---|---|---|
| Join | 2025 | EGX100 EWI | Egyptian Exchange |
| Join | 2025 | EGX70 EWI Index | Egyptian Exchange |
| Join | 2020 | Health Care & Pharmaceuticals | Egyptian Exchange |
| Leave | 2014 | EGX 100 | Egyptian Exchange |
| Leave | 2014 | EGX 70 | Egyptian Exchange |
| Join | 1995 | Egyptian Exchange |
| Memphis Pharmaceuticals |
| P.O. Box 11281, 8 El Sawah St., El Ameeriyah, Cairo, Egypt |
| T : +20 2 22823528 |
| F : +20 2 22843523 |
| www.memphis.com.eg |
| memphis@memphis.com.eg |
Management
| Title | Name | As Of |
|---|---|---|
| Chairman: | Essam Mohamed | |
| CEO: | Mohamed Abdel Azim | |
| Board Member: | Amani Kamal | 2021 |
| Adel Al Baily | 2023 | |
| Miral Darwish | ||
| Ali Abdel Sadek | 2025 |
Reports
| Date | Title | File |
|---|---|---|
| 2025 | Memphis Pharmaceuticals Annual Financials Report 2025 | |
| 2025 | Memphis Pharmaceuticals Quarterly Financials Report Q3 2025 | |
| 2025 | Memphis Pharmaceuticals Quarterly Financials Report Q2 2025 | |
| 2024 | Memphis Pharmaceutical Quarterly Financials Report Q1 2025 | |
| 2024 | Memphis Pharmaceutical Annual Financials Report 2024 | |
| 2024 | Memphis Pharmaceutical Quarterly Financials Report Q3 2024 | |
| 2024 | Memphis Pharmaceutical Quarterly Financials Report Q2 2024 | |
| 2023 | Memphis Pharmaceutical Quarterly Financials Report Q1 2024 | |
| 2023 | Memphis Pharmaceutical Annual Financials Report 2023 | |
| 2023 | Memphis Pharmaceutical Quarterly Financials Report Q3 2023 | |
| 2023 | Memphis Pharmaceutical Quarterly Financials Report Q2 2023 |
